Related Experiment Video

Updated: Jun 9, 2026

Induction and Micro-CT Imaging of Cerebral Cavernous Malformations in Mouse Model
05:12

Induction and Micro-CT Imaging of Cerebral Cavernous Malformations in Mouse Model

Published on: September 4, 2017

The pathogenetic features of cerebral cavernous malformations: a comprehensive review with therapeutic implications

Khaled M Krisht1, Kevin J Whitehead, Toba Niazi

  • 1Department of Neurosurgery, University of Utah, Salt Lake City, Utah 84132, USA.

Neurosurgical Focus
|September 3, 2010
PubMed

Insights

Cerebral cavernous malformations (CCMs) are vascular brain lesions. Research highlights the Ccm2 gene

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Cerebral cavernous malformations (CCMs) are common central nervous system (CNS) vascular lesions.
  • CCMs can cause seizures, neurological deficits, and hemorrhagic stroke.

Purpose of the Study:

  • To review the three identified CCM genes and their protein products.
  • To emphasize signaling pathways and interactions relevant to CCM pathogenesis.
  • To discuss therapeutic implications, particularly for the Ccm2 pathway.

Main Methods:

  • Review of human genetic studies identifying CCM-associated genes.
  • Analysis of biochemical and molecular studies in mouse models.
  • Focus on signaling pathways, especially involving the Ccm2 gene product.

Main Results:

  • Identification of three genes linked to CCM development.
  • Elucidation of signaling pathways with therapeutic potential.
  • Evidence supporting simvastatin or RhoA inhibitors for CCM treatment via the Ccm2 pathway.

Conclusions:

  • The Ccm2 signaling pathway offers therapeutic targets for CCM.
  • Further development of accurate animal models is needed.
  • Future research should focus on clinical and translational implications for CCM treatment.

More Related Videos

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations14:58

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations

Published on: October 20, 2017

Related Concept Videos

Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Cerebral Edema l: Introduction01:19

Cerebral Edema l: Introduction

Cerebral edema is a pathological increase in brain water content that disrupts intracranial pressure regulation and impairs neurological function. Because the cranial vault is rigid, even modest increases in tissue volume can compromise cerebral perfusion, distort neural structures, and initiate secondary injury. Cerebral edema develops through four principal mechanisms: vasogenic, cytotoxic, interstitial, and ionic.Vasogenic EdemaVasogenic edema arises from disruption of the blood–brain...